The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals

被引:23
作者
Chan, Kai En [1 ]
Ng, Cheng Han [1 ,11 ]
Fu, Clarissa Elysia [1 ]
Quek, Jingxuan [1 ]
Kong, Gwyneth [1 ]
Goh, Yi Jie [2 ]
Zeng, Rebecca Wenling [1 ]
Tseng, Michael [3 ]
Aggarwal, Manik [4 ]
Nah, Benjamin [2 ]
Chee, Douglas [2 ]
Wong, Zhen Yu [5 ]
Zhang, Sitong [6 ,7 ]
Wang, Jiong-Wei [6 ,7 ]
Chew, Nicholas W. S. [1 ,8 ]
Dan, Yock Young [1 ,2 ,9 ]
Siddiqui, Mohammad Shadab [3 ]
Noureddin, Mazen [1 ,10 ]
Sanyal, Arun J. [3 ]
Muthiah, Mark [1 ,2 ,9 ,12 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore
[2] Natl Univ Hlth Syst, Dept Med, Div Gastroenterol & Hepatol, Singapore, Singapore
[3] Virginia Commonwealth Univ, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA
[4] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[5] Nottingham Univ Hosp NHS Trust, Nottingham City Hosp, Nottingham, England
[6] Natl Univ Heart Ctr, Cardiovasc Res Inst CVRI, Dept Surg, Singapore, Singapore
[7] Natl Univ Singapore, Ctr Nanomed, Yong Loo Lin Sch Med, Nanomed Translat Res Programme, Singapore, Singapore
[8] Natl Univ Singapore Hosp, Natl Univ Heart Ctr, Dept Cardiol, Singapore, Singapore
[9] Natl Univ Hlth Syst, Natl Univ Ctr Organ Transplantat, Singapore, Singapore
[10] Houston Res Inst, Houston, TX USA
[11] Natl Univ Singapore, Yong Loo Lin Sch Med, 10 Med Dr, Singapore 117597, Singapore
[12] Div Gastroenterol & Hepatol, Tower Block Level 10,1E Kent Ridge Rd, Singapore 119228, Singapore
关键词
Nonalcoholic Fatty Liver Disease; Metabolic-associated Fatty Liver Disease; Metabolic Diseases; All-Cause Mortality; Adverse Outcomes;
D O I
10.1016/j.cgh.2022.09.028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Metabolic associated fatty liver disease (MAFLD) was recently proposed as an alternative name change for better encapsulation of disease. However, there exists a spectrum of MAFLD where both metabolically healthy (MH) and metabolically unhealthy (MU) individuals are included. In view of limited evidence, we sought to examine the prevalence, clinical characteristics, and differences in outcomes of MH-MAFLD at the population level. METHODS: Data were used from the United States National Health and Nutrition Examination Survey 1999 to 2018. Multivariate logistic regression analysis was used to obtain odds ratios for the estimation of events. Survival analysis was conducted with Cox regression and the Fine-Gray subdistribution model. RESULTS: There were 32,683 overweight and obese individuals included in the analysis. In MAFLD patients, the prevalence of MH-MAFLD was 6.92% (95% confidence interval [CI], 6.58%-7.27%), and 93.08% (95% CI, 92.73%-93.42%) were considered as MU-MAFLD. Multivariate analysis found a significantly higher risk of MACE (odds ratio, 1.38; 95% CI, 1.28-1.49; P <.01), all-cause (hazard ratio, 1.24; 95% CI, 1.17-1.32; P <.01), cardiovascular disease (SHR, 1.20; 95% CI, 1.02-1.42; P [.03), and cancer mortality (SHR, 1.24; 95% CI, 1.07-1.44; P <.01) in MU-MAFLD relative to non-MAFLD. However, MH-MAFLD individuals were not associated with a statistically significant increased risk of these adverse outcomes compared with non-MAFLD. MU-MAFLD diabetics were also at a higher risk of adverse events compared with non-diabetics. CONCLUSIONS: This study reports on the heterogeneity and spectrum of metabolic dysfunction that exists in overweight and obese MAFLD. Although MAFLD may potentially be advantageous in improving awareness and patient outcomes, there remains substantial heterogeneity within patients included in MAFLD on the basis of the underlying metabolic burden.
引用
收藏
页码:2560 / +
页数:25
相关论文
共 35 条
[1]  
[Anonymous], NHANES 2017-2018 data documentation
[2]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[3]  
Centers for Disease Control and Prevention, 2017, About the national health and nutrition examination survey
[4]   Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals [J].
Chan, Kai En ;
Koh, Tiffany Jia Ling ;
Tang, Ansel Shao Pin ;
Quek, Jingxuan ;
Yong, Jie Ning ;
Tay, Phoebe ;
Tan, Darren Jun Hao ;
Lim, Wen Hui ;
Lin, Snow Yunni ;
Huang, Daniel ;
Chan, Mark ;
Khoo, Chin Meng ;
Chew, Nicholas W. S. ;
Kaewdech, Apichat ;
Chamroonkul, Naichaya ;
Dan, Yock Young ;
Noureddin, Mazen ;
Muthiah, Mark ;
Eslam, Mohammed ;
Ng, Cheng Han .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (09) :2691-2700
[5]   Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality? [J].
Chen, Xu ;
Chen, Shen ;
Pang, Juan ;
Tang, Yi ;
Ling, Wenhua .
JOURNAL OF HEPATOLOGY, 2021, 75 (04) :987-989
[6]  
Chew NWS, 2022, Can J Cardiol
[7]   Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease [J].
Eddowes, Peter J. ;
Sasso, Magali ;
Allison, Michael ;
Tsochatzis, Emmanouil ;
Anstee, Quentin M. ;
Sheridan, David ;
Guha, Indra N. ;
Cobbold, Jeremy F. ;
Deeks, Jonathan J. ;
Paradis, Valerie ;
Bedossa, Pierre ;
Newsome, Philip N. .
GASTROENTEROLOGY, 2019, 156 (06) :1717-1730
[8]   The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease [J].
Eslam, Mohammed ;
Sarin, Shiv K. ;
Wong, Vincent Wai-Sun ;
Fan, Jian-Gao ;
Kawaguchi, Takumi ;
Ahn, Sang Hoon ;
Zheng, Ming-Hua ;
Shiha, Gamal ;
Yilmaz, Yusuf ;
Gani, Rino ;
Alam, Shahinul ;
Dan, Yock Young ;
Kao, Jia-Horng ;
Hamid, Saeed ;
Cua, Ian Homer ;
Chan, Wah-Kheong ;
Payawal, Diana ;
Tan, Soek-Siam ;
Tanwandee, Tawesak ;
Adams, Leon A. ;
Kumar, Manoj ;
Omata, Masao ;
George, Jacob .
HEPATOLOGY INTERNATIONAL, 2020, 14 (06) :889-919
[9]   A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement [J].
Eslam, Mohammed ;
Newsome, Philip N. ;
Sarin, Shiv K. ;
Anstee, Quentin M. ;
Targher, Giovanni ;
Romero-Gomez, Manuel ;
Zelber-Sagi, Shira ;
Wong, Vincent Wai-Sun ;
Dufour, Jean-Francois ;
Schattenberg, Joern M. ;
Kawaguchi, Takumi ;
Arrese, Marco ;
Valenti, Luca ;
Shiha, Gamal ;
Tiribelli, Claudio ;
Yki-Jarvinen, Hannele ;
Fan, Jian-Gao ;
Gronbaek, Henning ;
Yilmaz, Yusuf ;
Cortez-Pinto, Helena ;
Oliveira, Claudia P. ;
Bedossa, Pierre ;
Adams, Leon A. ;
Zheng, Ming-Hua ;
Fouad, Yasser ;
Chan, Wah-Kheong ;
Mendez-Sanchez, Nahum ;
Ahn, Sang Hoon ;
Castera, Laurent ;
Bugianesi, Elisabetta ;
Ratziu, Vlad ;
George, Jacob .
JOURNAL OF HEPATOLOGY, 2020, 73 (01) :202-209